altRx Reviews
One flat price at every dose for compounded GLP-1s, plus a brand-name shelf in the same account
Last updated: Sep 27, 2026
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
altRx has a genuinely useful pricing model - one flat price at every dose - and a brand-name shelf that makes switching easy, which is why it ranks third. But you should weigh it with eyes open: on June 8, 2026 the FDA issued a warning letter to its parent company, Trinity HealthCare Supply, LLC (dba altRx), objecting to website claims and product labels that presented its compounded semaglutide and tirzepatide as if they were FDA-approved drugs.
A warning letter is not a product recall or a finding that the medication harmed anyone, but it is a formal regulatory action worth factoring in, and you can read it on the FDA's website. Also watch the promo expiry - regular prices are high.
If the letter concerns you, embody offers a similar cash-pay model at a lower no-commitment price, and ro offers FDA-approved medication only. Results vary, and a licensed clinician decides whether a GLP-1 is right for you.
This review is general information, not medical advice.
altRx sells compounded semaglutide and tirzepatide at one flat price regardless of dose, which matters because many programs charge more as your dose climbs. It also offers brand-name Ozempic, Zepbound and Wegovy at self-pay list prices in the same account, so you can switch without changing providers.
The intake is fast and asynchronous, with video when needed and a tracking app. One thing every reader should know before signing up: on June 8, 2026 the FDA issued a warning letter to altRx's parent company, Trinity HealthCare Supply, LLC (dba altRx), because, in the agency's view, its marketing and labels made its compounded semaglutide and tirzepatide look FDA-approved.
Compounded GLP-1s are not FDA-approved. This review covers altRx's pricing, how it works and how to weigh that letter.
Key Features
- Compounded semaglutide $89/month and tirzepatide $149/month (promo rates)
- Flat price at every dose - no increase as you titrate up
- Brand-name shelf: Ozempic, Zepbound and Wegovy at self-pay list prices
- No commitment - pause or cancel anytime; Buy Now, Pay Later available
- Fast async intake, video when needed, tracking app
- Free shipping, arrives in 5-7 days
Treatment Options
- Compounded semaglutide (flat price at every dose)
- Compounded tirzepatide (flat price at every dose)
- Brand-name Ozempic, Zepbound and Wegovy (self-pay)
- Async intake, video when needed and a progress-tracking app
Pricing
Semaglutide
Promo rate, time-limited - no commitmentCompounded semaglutide
- Same price at every dose
- Free shipping (5-7 days)
- Buy Now, Pay Later
Tirzepatide
Promo rate, time-limited - no commitmentCompounded tirzepatide
- Same price at every dose
- Pause or cancel anytime
- Tracking app
Brand-name shelf
Self-pay list pricesOzempic / Zepbound / Wegovy
- Ozempic $1,149/mo
- Zepbound $1,249/mo
- Wegovy $1,579/mo
altRx charges one flat price at every dose: compounded semaglutide is $89/month on promo (regular $199) and compounded tirzepatide is $149/month on promo (regular $299). Promo rates are time-limited - after the promotion you pay the regular price, which is well above most competitors, so check which rate applies to you.
Brand-name medication is also available at self-pay list prices: Ozempic $1,149/month, Zepbound $1,249/month and Wegovy $1,579/month. Shipping is free and there is no commitment.
Note that altRx received an FDA warning letter dated June 8, 2026 about how it marketed its compounded products, and compounded GLP-1s are not FDA-approved.
How altRx Works
- 1Step 1
Fast online intake
Complete an asynchronous health questionnaire covering your weight, history and current medications.
- 2Step 2
Clinician review
A licensed clinician reviews your intake - with a video visit when needed - and decides whether a GLP-1 is appropriate and which one.
- 3Step 3
Delivery in 5-7 days
If prescribed, medication ships free. Track your progress in the app and pause or cancel whenever you choose.
Pros
- Same price at every dose, so costs do not rise as you step up
- Competitive promo pricing: semaglutide $89/month, tirzepatide $149/month
- Brand-name options in the same account if you want to switch
- No commitment, plus Buy Now, Pay Later
Cons
- FDA warning letter (June 8, 2026) to its parent company saying its marketing overstated its compounded GLP-1s and its labels suggested FDA approval
- Compounded medication is not FDA-approved or FDA-reviewed for safety, effectiveness or quality
- Promo prices are time-limited; regular prices ($199 / $299) are among the highest on our list
- Slower delivery than rivals - 5-7 days
- No published Trustpilot rating to cross-check customer experience
Who It's Best For
- People who expect to reach higher doses and want one flat price throughout
- Those who want compounded and brand-name options under one provider
- Skip it if an FDA warning letter is a deal-breaker for you, or if you need medication fast - embody ships in 1-2 days
Final Verdict
altRx has a genuinely useful pricing model - one flat price at every dose - and a brand-name shelf that makes switching easy, which is why it ranks third. But you should weigh it with eyes open: on June 8, 2026 the FDA issued a warning letter to its parent company, Trinity HealthCare Supply, LLC (dba altRx), objecting to website claims and product labels that presented its compounded semaglutide and tirzepatide as if they were FDA-approved drugs.
A warning letter is not a product recall or a finding that the medication harmed anyone, but it is a formal regulatory action worth factoring in, and you can read it on the FDA's website. Also watch the promo expiry - regular prices are high.
If the letter concerns you, embody offers a similar cash-pay model at a lower no-commitment price, and ro offers FDA-approved medication only. Results vary, and a licensed clinician decides whether a GLP-1 is right for you.
This review is general information, not medical advice.
altRx Review: FAQs
Is altRx legit?
altRx sells compounded semaglutide and tirzepatide at one flat price regardless of dose, which matters because many programs charge more as your dose climbs. It also offers brand-name Ozempic, Zepbound and Wegovy at self-pay list prices in the same account, so you can switch without changing providers. The intake is fast and asynchronous, with video when needed and a tracking app. One thing every reader should know before signing up: on June 8, 2026 the FDA issued a warning letter to altRx's parent company, Trinity HealthCare Supply, LLC (dba altRx), because, in the agency's view, its marketing and labels made its compounded semaglutide and tirzepatide look FDA-approved. Compounded GLP-1s are not FDA-approved. This review covers altRx's pricing, how it works and how to weigh that letter.
How much does altRx cost?
altRx charges one flat price at every dose: compounded semaglutide is $89/month on promo (regular $199) and compounded tirzepatide is $149/month on promo (regular $299). Promo rates are time-limited - after the promotion you pay the regular price, which is well above most competitors, so check which rate applies to you. Brand-name medication is also available at self-pay list prices: Ozempic $1,149/month, Zepbound $1,249/month and Wegovy $1,579/month. Shipping is free and there is no commitment. Note that altRx received an FDA warning letter dated June 8, 2026 about how it marketed its compounded products, and compounded GLP-1s are not FDA-approved.
What treatments does altRx offer?
altRx offers Compounded semaglutide (flat price at every dose), Compounded tirzepatide (flat price at every dose), Brand-name Ozempic, Zepbound and Wegovy (self-pay), Async intake, video when needed and a progress-tracking app.
Who is altRx best for?
altRx is best for People who expect to reach higher doses and want one flat price throughout; Those who want compounded and brand-name options under one provider; Skip it if an FDA warning letter is a deal-breaker for you, or if you need medication fast - embody ships in 1-2 days.
Is altRx worth it?
altRx has a genuinely useful pricing model - one flat price at every dose - and a brand-name shelf that makes switching easy, which is why it ranks third. But you should weigh it with eyes open: on June 8, 2026 the FDA issued a warning letter to its parent company, Trinity HealthCare Supply, LLC (dba altRx), objecting to website claims and product labels that presented its compounded semaglutide and tirzepatide as if they were FDA-approved drugs. A warning letter is not a product recall or a finding that the medication harmed anyone, but it is a formal regulatory action worth factoring in, and you can read it on the FDA's website. Also watch the promo expiry - regular prices are high. If the letter concerns you, embody offers a similar cash-pay model at a lower no-commitment price, and ro offers FDA-approved medication only. Results vary, and a licensed clinician decides whether a GLP-1 is right for you. This review is general information, not medical advice.
Related
Sources & methodology
We built this review of altRx from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- altRx - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 2.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize - U.S. Food & Drug Administration
- 3.Wegovy (semaglutide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 4.Zepbound (tirzepatide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 5.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) - Wilding et al. - New England Journal of Medicine, 2021;384:989-1002
- 6.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) - Jastreboff et al. - New England Journal of Medicine, 2022;387:205-216
- 7.Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) - Aronne et al. - New England Journal of Medicine, 2025
- 8.Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension - Wilding et al. - Diabetes, Obesity and Metabolism, 2022
- 9.Prescription Medications to Treat Overweight & Obesity - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.